Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. PRIM
6. META
7. DPZ
8. N2EW34
9. INTC
10. IMNN

Go back to Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
(NASDAQ: OCUL) Delayed: 9.97 --0 (-0%)
Previous Close $9.97    52 Week High $14.50 
Open $9.97    52 Week Low $4.04 
Day High $9.97    P/E N/A 
Day Low $9.97    EPS $0.00 
Volume 30,095